Institutional Ownership Vertex Pharmaceuticals Inc (VRTX)
This table provides information about the institutional ownership of Vertex Pharmaceuticals Inc (VRTX). We have compiled data on the 1,716 institutions that hold shares in the stock, with a total of 225 Million shares, which have been reported (via 13F filing form) to have a value of $113 Billion.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Birch Hill Investment Advisors LLC
|
Oct 10, 2024 Q3 2024 |
168,157
shares
|
$84.5 Million
3.8% of portfolio
|
Q3 2024
Reduced 1.95%
|
|
Amf Tjanstepension Ab
|
Oct 28, 2024 Q3 2024 |
167,918
shares
|
$84.4 Million
0.58% of portfolio
|
Q3 2024
Reduced 69.45%
|
|
Perpetual LTD
Sydney, New South Wales, C3 |
Oct 09, 2024 Q3 2024 |
167,221
shares
|
$84 Million
0.84% of portfolio
|
Q3 2024
Reduced 1.74%
|
|
Atalanta Sosnoff Capital, LLC
|
Aug 13, 2024 Q2 2024 |
161,255
shares
|
$81 Million
1.7% of portfolio
|
Q2 2024
Reduced 4.05%
|
|
Provident Investment Management, Inc.
Novi, MI |
Aug 07, 2024 Q2 2024 |
159,862
shares
|
$80.3 Million
7.21% of portfolio
|
Q2 2024
Reduced 0.16%
|
|
Guggenheim Capital LLC
Chicago, IL |
Aug 14, 2024 Q2 2024 |
159,687
shares
|
$80.2 Million
0.54% of portfolio
|
Q2 2024
Reduced 3.63%
|
|
Cookson Peirce & CO Inc
|
Aug 13, 2024 Q2 2024 |
156,169
shares
|
$78.5 Million
3.58% of portfolio
|
Q2 2024
Added 9.22%
|
|
Manning & Napier Advisors LLC
Fairport, NY |
Oct 17, 2024 Q3 2024 |
155,761
shares
|
$78.3 Million
0.8% of portfolio
|
Q3 2024
Reduced 1.62%
|
|
Ci Private Wealth, LLC
Miami, FL |
Aug 13, 2024 Q2 2024 |
154,820
shares
|
$77.8 Million
0.13% of portfolio
|
Q2 2024
Added 1.5%
|
|
Van Eck Associates Corp
|
Oct 29, 2024 Q3 2024 |
151,428
shares
|
$76.1 Million
0.09% of portfolio
|
Q3 2024
Added 4.55%
|
|
Orbimed Advisors LLC
San Diego, CA |
Aug 14, 2024 Q2 2024 |
151,000
shares
|
$75.9 Million
1.71% of portfolio
|
Q2 2024
Added 23.06%
|
|
State Of Wisconsin Investment Board
Madison, WI |
Aug 14, 2024 Q2 2024 |
149,254
shares
|
$75 Million
0.19% of portfolio
|
Q2 2024
Reduced 7.85%
|
|
Pfm Health Sciences, LP
San Francisco, CA |
Aug 14, 2024 Q2 2024 |
148,852
shares
|
$74.8 Million
3.58% of portfolio
|
Q4 2023
New holding
|
|
Nomura Asset Management CO LTD
Tokyo, M0 |
Aug 14, 2024 Q2 2024 |
148,063
shares
|
$74.4 Million
0.24% of portfolio
|
Q2 2024
Added 12.71%
|
|
Israel Englander
Millennium Management LLC | New York, Ny
|
Aug 14, 2024 Q2 2024 |
142,759
shares
|
$71.7 Million
0.03% of portfolio
|
Q2 2024
Reduced 56.05%
|
|
Baillie Gifford & CO
|
Nov 05, 2024 Q3 2024 |
140,580
shares
|
$70.6 Million
0.05% of portfolio
|
Q3 2024
Reduced 16.13%
|
|
Hudson Bay Capital Management LP
Greenwich, CT |
Aug 14, 2024 Q2 2024 |
137,500
shares
|
$69.1 Million
0.35% of portfolio
|
Q2 2024
New holding
|
|
Asset Management One Co., Ltd.
|
Oct 30, 2024 Q3 2024 |
135,187
shares
|
$67.9 Million
0.23% of portfolio
|
Q3 2024
Added 1.07%
|
|
Glenmede Trust CO Na
Philadelphia, PA |
Aug 14, 2024 Q2 2024 |
132,818
shares
|
$66.7 Million
0.32% of portfolio
|
Q2 2024
Reduced 1.68%
|
|
Treasurer Of The State Of North Carolina
|
Aug 14, 2024 Q2 2024 |
131,919
shares
|
$66.3 Million
0.26% of portfolio
|
Q2 2024
Added 0.9%
|
|
Toronto Dominion Bank
Toronto, Ontario, A6 |
Aug 14, 2024 Q2 2024 |
131,106
shares
|
$65.9 Million
0.1% of portfolio
|
Q2 2024
Reduced 14.29%
|
|
Janney Montgomery Scott LLC
|
Oct 29, 2024 Q3 2024 |
127,425
shares
|
$64 Million
0.17% of portfolio
|
Q3 2024
Reduced 1.84%
|
|
Antipodes Partners LTD
Royal Exchange, C3 |
Aug 05, 2024 Q2 2024 |
127,295
shares
|
$64 Million
2.2% of portfolio
|
Q2 2024
Reduced 32.79%
|
|
Marshall Wace, LLP
London, X0 |
Aug 14, 2024 Q2 2024 |
127,000
shares
|
$63.8 Million
0.08% of portfolio
|
Q2 2024
Reduced 32.14%
|
|
Capital International Sarl
Los Angeles, CA |
Aug 13, 2024 Q2 2024 |
124,080
shares
|
$62.3 Million
1.85% of portfolio
|
Q2 2024
Added 6.53%
|